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ABSTRACT
Angiotensin I-converting enzyme (ACE) inhibitors have a potent antihypertensive effect in both humans and animals. Various
peptides derived from food proteins were found to have ACE inhibitory activity. For determining ACE inhibitory activity, protein
hydrolysates were prepared from tuna broth (contain 4% water-soluble protein) using various commercial proteases. Orientase
hydrolysate (OAH) exhibited the most potent inhibitory activity on ACE. The best hydrolysis conditions with respect to inhibition of
ACE were 3hr of incubation at 50˚C, pH 6.5, with enzyme (1.0% orientase) to substrate (tuna broth) of 1/25 (v/v). Preparation under
these conditions yielded activity (IC50 12.52 ± 0.02 mg/mL). Fractionation of the orientase hydrolysate on a Sephadex G-25 gel filtration chromatograph resulted in the production of more active inhibitors. The active fractions were peptides of molecular weights <
1,000 Da. The most active fraction had an IC50 value of 0.21 ± 0.01 mg/mL. This fraction was rich in basic amino acids and aromatic
amino acids [peptides with molecular mass (< 565 Da)].
Key words: angiotensin I-converting enzyme (ACE), protein hydrolysate, peptide, tuna broth

INTRODUCTION
Angiotensin I-converting enzyme (ACE, peptidyl
dipeptidase, EC 3.4.15.1) is important in regulating blood
pressure. In the rennin angiotensin system, ACE acts on
angiotensin I to hydrolyze His-Leu from its C-terminal and
produces a potent vasopressor aginotensin II(1). In addition,
in the kinin kallikrein system, ACE inactivates bradykinin,
which performs a vasodilatory action(2). Accordingly, ACE
elevates blood pressure. Some inhibitors of ACE show
antihypertensive effects in vivo and are used as pharmaceuticals(3). Recently, ACE inhibitory peptides derived from
hydrolystates of casein, fish muscle, and other food proteins
were isolated(4-7). The oral administration of these peptides
reduced blood pressure in spontaneously hypertensive rats
(SHR) and also inhibited the presser effect of intravenously
administrated angiotensin-I in normotensive rats(8).
Tuna broth, a protein-rich stock (4% water-soluble
protein) of the tuna canning industry is discarded as
waste(9). Canned tuna is the most valuable commercial
canned fishery products in Taiwan, with an annual production of over 2,470 tons(10). One tuna processing plant
produces over 15 tons/day of tuna broth, which contains
valuable proteins. This effluent causes not only water
pollution but also loss of a potentially valuable protein
resource(11). Thus, the protein should be recovered and
utilized. The authors prepare from tuna broth a hydrolysate
with ACE inhibitory activity that could be applied as a new
* Author for correspondence. Tel: +886-4-8511888 ext. 4191;
Fax: +886-4-22873208; E-mail: wcko@mail.dyu.edu.tw

source of physiologically functional food material. The
proteolysis conditions of the bioactive hydrolysates and
their characteristics were investigated in this work.

MATERIALS AND METHODS
I. Tuna Broth
The tuna broth was obtained from a tuna-canning
factory in Chiayi, Taiwan. Tuna fish meat was cooked with
steam (100-105˚C) for 3hr. After the cooked meat was
cooled, the soup base was filtered through two layers of
gauze to remove any floating fat and solids. The collected
liquid was vacuum-packed in 400-g polyethylene bags and
stored at -30˚C.
II. Enzymes and Chemicals
Four commercial enzymes, orientase (derived from
Bacillus subtilis, 70,000 Folin units/mg, Hankyu Co.,
Tokyo, Japan), protease XXIII (3.8 Folin units/mg, Sigma
Chemical Co., LA, USA), papain (1.7 units/mg, one unit
will hydrolyze 1.0 µmole of BAFE per min at 25˚C, pH
6.2, Sigma Chemical Co., LA, USA) and trypsin (protease
activity: 24 IU/l, Sigma Chemical Co., LA, USA), were
selected on the basis of their potential to hydrolyze fish
protein in a preliminary hydrolysis assay. All chemicals
used were of reagent grade and obtained from Sigma Co.
(USA).
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III. Preparation of Hydrolysates
A 25 mL-sample of tuna broth (adjusted to pH 6.5
with 0.1N NaOH) containing about 4% protein (w/v) was
hydrolyzed with individual protease at a ratio of substrate
to enzyme of 25 (v/v). Hydrolysis was performed at pH
6.5. The pH was monitored and adjusted every 30 min by
addition of 0.5 M NaOH or 1M HCl during the hydrolysis
period. The content of soluble protein in tuna broth
depended on pH and the highest solubility was observed at
pH between 5.5 and 6.5(9). The following experiments
were performed on broth at pH 6.5 to maximize solubility
(since it was close to 6.28, the pH value of tuna broth),
although this pH value differs from the optimum pH value
for the activity of the four enzymes (optimum pH of
orientase is 7.0, protease XIII pH 7.5; papain pH 7.5;
trypsin pH 7.5). The temperature of the reaction mixtures
was adjusted to the optimum temperature of each enzyme,
for the duration of hydrolysis. After the reaction proceeded
for the set hydrolysis, it was terminated by immersing the
reaction vessel into a water bath (100˚C) for 10 min with
occasional stirring to inactivate enzymes. After cooling,
the hydrolysate was centrifuged at 10,000 ×g for 10 min.
The supernatant was collected, frozen at -70˚C and then
freeze-dried.
IV. Analysis of Free Amino Acids
The free amino acids were characterized upon the
enzymatic hydrolysates of tuna broth, according to the
procedure of Moore and Stein(12). The protein hydrolysate
(15 mL) was added with 10 mL of 15% TCA for 30 min,
and centrifuged (10 min at 10,000 ×g). The supernatants
were freeze-dried after being frozen overnight at -30˚C, and
placed into a 25-mL volumetric flask together with 10 mL
of a 0.2 M citrate buffer (pH 2.2). The quantity and type of
free amino acids present were determined with the
ninhydrin regent with amino acid standards using a High
Performance Amino Acid Analyzer (Beckman 6300, San
Ramon, CA95483, USA), column: cation exchange resin,
analysis temperature: 50-70˚C, cuvette length: 12 mm,
citrate buffer (0.2 M, pH 2.2) flow rate: 20 mL/hr,
ninhydrin flow rate: 10 mL/hr.

activity. The inhibition rate (%) is shown as {(Ec-Es/EcEb)} × 100, where Es is the absorbance when the sample is
added to the reaction mixture; Ec is the absorbance with
buffer (instead of the sample) added, and Eb is the
absorbance when the stop solution was added before the
reaction occurred. The IC50 value was expressed in terms
of mg protein/mL. The % of ACE inhibition versus log10
[hydrolysate] (mg/mL) curve was constructed using at least
seven separate analyses (different concentrations). The
IC50 value is the concentration when 50% of ACE activity
was inhibited.
VI. Protein Determination
Protein concentrations were determined by the Lowry
method(14). Triplicate assays were performed for each
sample and bovine serum albumin (100 µg/mL, 50 µg/mL,
25 µg/mL, 12.5 µg/mL) was used as the protein standard (r2
= 0.9979).
VII. Molecular Weight (MW) Distribution by Gel Filtration
Freeze-dried powder (280 mg) obtained from protease
hydrolysis was dissolved in 1 mL of distilled water and
applied on a Sephadex G-25 column (2.5 × 70 cm), which
was eluted with 0.05 M phosphate buffer, pH 6.5.
Fractions in 5 mL were collected at a flow rate of 45
mL/hr. The absorbance at 280 nm and the ACE inhibitory
activity of all fractions were measured. The distribution of
MW of hydrolysate was estimated using β-endothein
(M.W. 2,573), [Sar1, Ala8] angiotensin-II (M.W. 926), Nformyl-Met-Leu-Phe-Lys (M.W. 565.7) and tryptophan
(M.W. 204) for calibration.

RESULTS
I. Selection of Protease for Hydrolysis of Tuna Broth

V. Characterization of ACE Inhibition

Table 1 summarizes the ACE inhibition indices
obtained from the hydrolysates of tuna broth. The original
tuna broth showed an extremely low (< 5%) ACE inhibition, which increased after hydrolysis with orientase,
papain, trypsin, and protease XXIII. Among the four
hydrolysates, orientase digest showed the strongest ACE

ACE inhibitory activity was measured spectrophotometrically using hippuryl-L-histidyl-L-leucine (Hip-HisLeu) as substrate according to the method of Cushman and
Cheung(13). A 50-µL sample solution and 100 µL of 2.5
mU ACE (from rabbit lung obtained from Sigma Co. USA)
solution were added to 100 µL of 12.5 mM Hip-His-Leu
solution in 1.0 M NaCl-borate buffer at pH 8.3. After incubation at 37˚C for 1 hr, the reaction was stopped by adding
250 µL of 0.5 N HCl. The liberated hippuric acid was
extracted with 1.5 mL of ethyl acetate, and its absorbance
at 228 nm was determined to evaluate the ACE inhibitory

Table1. Inhibition of ACE by enzymatic hydrolyzates of tuna broth
Enzyme
ACE-inhibition rate (%)a
Orientase
62.2 ± 2.1
Protease XXIII
24.5 ± 2.5
Papain
34.1 ± 2.1
Trypsin
25.9 ± 1.9
None
3.0 ± 1.3
a
Tuna broth was hydrolyzed with individual enzyme preparations (at
a ratio of each enzyme solution (1.0%) to substrate of 1/25 (v/v) for
2 hr at the optimum temperature for each enzyme, pH 6.5). Orientase
at 50˚C, protease XXIII at 37˚C, papain at 25˚C, trypsin at 37˚C.
Values are mean ± standard deviation (n = 3).
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II. Inhibition of ACE Using Orientase Hydrolysates
Figure 1 shows the effect of proteolysis time and
orientase concentration on the inhibition of ACE at 50˚C at
an enzyme (0.1, 0.5, 1.0, 2.0% orientase)/substrate (tuna
broth) ratio of 1/25 (v/v). With the addition of 1.0 and
2.0% enzyme, the activity reached the maximal value
(about 77.45%) after 3 hr of proteolysis and then leveled
off, while at 0.1% and 0.5%, the maximal activity of 33%
and 51%, respectively, were obtained after 6 hr of hydrolysis. Hydrolysates with ACE inhibition index values > 50%
were selected for the determination of the IC50 value, which
is the amount of hydrolysate that inhibits ACE activity by
50%. Table 2 summarizes the IC 50 value of orientase
hydrolysates prepared under optimal conditions to show the
maximal inhibitory activity at each concentration (0.5, 1.0,
2.0%) of enzyme added shown in Figure 1. The IC50 value
associated with the maximum inhibitory activity was 12.52
± 0.02 mg/mL for 1.0% orientase and 12.50 ± 0.02 mg/mL
for 2.0% orientase after 3 hr incubation. The two
hydrolysates differ insignificantly in IC50 values. Table 3
indicates similar pattern in the amino acid composition for
the two hydrolysates prepared.
III. Fractionation of Hydrolysate and ACE Inhibitory
Activity
The apparent molecular weight distribution of peptides
in hydrolysate prepared with 1.0% orientase for 3 hr was
estimated by gel filtration on a Sephadex G-25 column
(Figure 2). The gel filtration showed four major fractions,

OA1 (no. 13-15, retention time 81-100 min, M.W. > 2573),
OA2 (no. 31-33, retention time 201-230 min, 926 > M.W. >
565), OA3 (no. 39-41, retention time 254-273 min, M.W. <
565) and OA4 (no. 46-48, retention time 300-320 min,
M.W. < 565). The active fractions were those that contained
Table 2. IC50 values of orientase hydrolysates prepared from tuna
broth under various conditions
Enzyme (%)
Hydrolysis timea (hr)
IC50b (mg/mL)
0.5
6
26.58 ± 0.01
1.0
3
12.52 ± 0.02
2.0
3
12.50 ± 0.02
a
Hydrolysis was performed at 50˚C at pH 6.5 at an enzyme (0.5, 1.0,
2.0% orientase)/substrate (tuna broth) ratio of 1/25 (v/v) for the
specified time to yield the maximum activity shown in Figure 1.
b
Values are mean ± standard deviation (n = 3).
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to prepare hydrolysate in the following experiments.
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Figure 1. Effect of proteolysis time on inhibition of ACE as a
function of orientase concentration.
Tuna broth was hydrolyzed by orientase at 50˚C, pH 6.5 and a ratio
of enzyme solution (0.1, 0.5, 1.0, 2.0% orientase) to substrate of 1/25
(v/v).

Table 3. Amino acid contents of orientase hydrolysates of tuna broth
Amino acids (µmol/mL)
Tuna broth
1.0%-3 hr proteolysisa
2.0%-3 hr proteolysisa
b
b
Asp
258.52 (0.82)
257.16 (1.36)
257.06 (1.46)b
Tau
156.51 (7.58)
144.53 (11.98)
144.65 (11.86)
Thr
129.63 (0.78)
128.35 (1.28)
128.19 (1.44)
Ser
128.01 (0.88)
126.55 (1.46)
126.37 (1.64)
Glu
317.27 (1.19)
315.22 (2.05)
314.96 (2.31)
Pro
289.91 (0.61)
288.96 (0.95)
288.73 (1.18)
Gly
946.05 (0.84)
944.4 (1.65)
944.21 (1.84)
Ala
431.42 (1.73)
428.2 (3.22)
427.75 (3.67)
Val
148.13 (1.11)
146.32 (1.81)
146.1 (2.03)
Hcy
92.10 (0.09)
91.87 (0.23)
91.87 (0.23)
Met
58.04 (0.47)
57.1 (0.94)
57.1 (0.94)
Ile
55.26 (0.65)
54.09 (1.17)
53.97 (1.29)
Leu
112.66 (1.41)
110.25 (2.41)
110.06 (2.60)
Tyr
37.91 (0.57)
37.05 (0.86)
36.99 (0.92)
Phe
63.90 (0.62)
61.78 (2.12)
61.88 (2.02)
Trp
3.75 (0.06)
3.68 (0.07)
3.65 (0.10)
Lys
171.13 (1.05)
169.39 (1.74)
169.24 (1.89)
His
215.15 (5.81)
205.75 (9.4)
205.13 (10.02)
Arg
28.12 (0.90)
26.89 (1.23)
26.74 (1.38)
Total
3643.47 (27.17)
3597.54 (45.93)
3594.65 (48.82)
a
Proteolysis was performed at a ratio of enzyme solution (1.0% , 2.0% orientase) to substrate of 1/25 (v/v) at 50˚C for 3hr.
b
Figure in parentheses shows the contents of free amino acid in tuna broth or hydrolysates.
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Figure 2. Sephadex G-25 gel filtration profile of hydrolysate obtained
from tuna broth by 1.0% orientase.
Eluent: 0.05M phosphate buffer (pH 6.5); flow rate: 45 mL/hr.
MW was estimated using β-endothein (M.W. 2,573), [Sar1, Ala8]
angiotensin-II (M.W. 926), N-formyl-Met-Leu-Phe-Lys (M.W. 565.7)
and tryptophan (M.W. 204).

peptides of molecular weights < 1,000 Da (Table 4). OA1,
having higher molecular weight, did not affect ACE.
Among the active fractions, OA3 inhibited ACE most
strongly (IC50 = 0.21 ± 0.01 mg protein/mL), and the IC50
values for OA2 and OA4 were 25.26 ± 0.02 and 0.52 ± 0.03
mg protein/mL, respectively.
IV. Amino Acid Content in Hydrolysates
Table 4 summarizes the amino acid content in OA1,
OA2, OA3 and OA4 fractions. The mole % of basic amino
acids (Lys, His, Arg) for OA1, OA2, OA3 and OA4 were
4.70, 5.18, 9.49 and 7.35, and aromatic amino acids (Phe,
Tyr, Trp) were 0.98, 0.95, 2.23 and 1.34, respectively. OA3
contained more basic and hydrophobic amino acids than the
other fractions (Figure 3).

DISCUSSION
Peptides that inhibit ACE have been found in many
different food protein hydrolysates(15). For each enzyme
treatment in this study, all hydrolysates were capable of
inhibiting ACE, indicating that ACE inhibition was brought
about by any peptides. These peptides were inactive in the
proteins existing in tuna broth and were released during
enzymatic hydrolysis. Consequently, proteins in tuna broth
are a source of ACE inhibitory peptides.
Orientase treatments were applied to determine the best
proteolysis conditions. The results (Figure 1) showed that
the development of activity on ACE with the addition of
1.0% orientase was similar to that of 2%. The hydrolysis
curve is similar to that reported for sardine muscle
hydrolysate(5). A slight difference between the IC50 values
for 1.0 and 2.0% enzyme addition indicates the appropriate
proteolysis conditions for yielding inhibitory activity, which
required 3hr of incubation with 1.0% orientase. The activity
of the alkaline protease hydrolysate derived from sardine
muscle (IC50 = 3.15 mg/mL)(5) was about 4.1 fold higher

5

0
N

A

B

Ar

C

Amino acids

Figure 3. Amino acid contents of fractions OA1, OA2, OA3 and
OA4.
N: neutral amino acids, including Gly, Ala, Ser, Thr, Val, Leu, ILe.
A: acidic amino acids, including Asp and Glu.
B: basic amino acids, including Lys, His, Arg.
Ar: aromatic amino acids, including Phe, Tyr and Trp.
C: cyclic amino acids, including Pro.

than that of the prepared hydrolysate (IC50 = 12.50 ± 0.02
mg/mL). This difference may result from the proteases
used.
The orientase hydrolysate was fractionated to
determine the distribution of molecular weight of the active
peptides. The results indicated that peptides with molecular
mass of 204 to 926 Da were responsible for the ACE inhibition. This finding was consistent with the literature, in
which ACE inhibitory peptides were shown to have
molecular weights usually of 2-14 amino acids(16).
Antihypertensive effects of food protein-derived
hydrolysates/peptides in rats and humans have been
studied(17-21). Astawan et al.(22) reported that a pepsin
hydrolysate of dried-salted fish with an IC50 value of 0.63
mg/mL had an antihypertensive effect on SHR. The IC50
value of the tuna broth hydrolysates (OA3 and OA4, IC50 =
0.21± 0.01 and 0.52 ± 0.03 mg/mL, respectively) was thus
within the range of effective IC 50 of the food protein
hydrolysates reported in literature (Table 4), but had lower
ACE inhibiting potencies than the synthetic antihypertensive drug captopril (IC50 = 0.0013 µg/mL)(23). However,
the application of cooking juice hydrolysates in treating/
preventing hypertension unlike captopril, are expected to
have no undesirable side effects.
Comparison of the amino acid compositions and the
properties of the fractions OA1, OA2, OA3, OA4 (Figure 3
and Table 4) reveals that OA3, the most active fraction is
apparently had an abundance of basic and aromatic amino
acids. Cheung et al.(16) reported that a peptide had aromatic
amino acid residues at its C-terminal and basic or hydrophobic ones at its N-terminal were essential for strong and competitive inhibition on ACE. Seki et al.(24) also reported aromatic amino acids and basic amino acids are important to
ACE inhibition of peptides. In this study, a greater mole
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Table 4. Comparison of IC50 values, amino acid contents of hydrolysate fractions from tuna broth prepared with orientase comparing to the
sardine muscle hydrolysate (SMH)
Amino acids (mole %)
OA1
OA2
OA3
OA4
SMHa
Asp
5.87
1.89
1.90
1.71
8.97
Tau
0.02
N.D
N.D
N.D
Thr
1.97
0.95
0.96
0.72
4.49
Ser
1.83
1.15
1.04
0.95
5.05
Glu
4.05
1.75
2.12
1.77
12.79
Pro
4.69
0.97
1.07
1.03
3.70
Gly
9.17
2.89
5.22
2.48
8.75
Ala
3.22
1.97
1.93
1.66
8.19
1/2Cys
0.17
0.12
0.12
0.22
1.01
Val
1.87
1.15
1.14
1.12
7.52
Met
0.27
0.16
0.05
0.08
4.38
Ile
1.24
0.82
0.88
0.73
4.38
Leu
1.88
1.21
1.43
1.14
8.64
Tyr
0.32
0.36
0.84
0.18
2.25
Phe
0.44
0.50
0.98
0.86
2.02
Trp
0.13
0.09
0.41
0.30
1.57
Lys
1.29
0.75
1.27
0.86
7.86
His
0.53
0.85
0.54
0.79
4.83
Arg
2.88
3.58
7.68
5.70
3.59
58.16
78.84
70.42
77.79
NH3
IC50 (mg /mL)
--b
25.26 ± 0.02
0.21 ± 0.01
0.52 ± 0.03
026
a
Data from Matsui et al.(5)
b
---: no inhibition activity on ACE.
OA1, OA2, OA3 and OA4: fractions of hydrolysates prepared from tuna broth using 1.0% orientase at a ratio of enzyme to substrate of 1/25
(v/v) incubated at 50˚C for 3 hr.

(%) fraction of aromatic amino acids or basic amino acids in
the fractions obtained from orientase hydrolysate was associated with a greater observable inhibition on ACE (Table
4).
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